Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Justin A. Weldon"'
Autor:
Shi Ming Tu, Sumit K. Subudhi, Ana Aparicio, Ioannis Alafis, Brian F. Chapin, Xuemei Wang, Myrto Boukovala, Paul G. Corn, Nicholas Spetsieris, John C. Araujo, Justin A. Weldon, Eleni Efstathiou, Jennifer Wang, Lisa Pruitt, Christopher J. Logothetis, Amado J. Zurita, John Papadopoulos, John J. Davis
Publikováno v:
European Journal of Cancer. 157:259-267
Background Intermittent androgen deprivation therapy (ADT) in biochemically recurrent castration-naive prostate cancer is non-inferior to continuous therapy. We hypothesised that finite-duration abiraterone acetate plus prednisone (Abi +P) added to A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::282c245b98b96574c5edaa7dd1db4db7
https://doi.org/10.1016/j.ejca.2021.06.017
https://doi.org/10.1016/j.ejca.2021.06.017
Autor:
John C. Araujo, Christopher J. Logothetis, Jeri Kim, Eleni Efstathiou, Justin A. Weldon, Ana Aparicio, Lance C. Pagliaro, Jennifer L. Wang, Nicholas Spetsieris, Alexandros Tsikkinis, Paul G. Corn, Sijin Wen, Anh G Hoang, Shi Ming Tu, Nizar M. Tannir, Sumit K. Subudhi, Myrto Boukovala, Amado J. Zurita, Patricia Troncoso
Publikováno v:
Eur J Cancer
BACKGROUND: The unmet need for predictive biomarkers emerged from the unpredictable pattern of response to androgen signaling inhibition in metastatic castration-resistant prostate cancer (mCRPC). Here, we report on the testing of a previously identi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::017fe1842dd3c6412e933a86e6c6d94b
https://doi.org/10.1016/j.ejca.2019.12.027
https://doi.org/10.1016/j.ejca.2019.12.027
Autor:
Surena F. Matin, Mercedes F Villarreal, Christine C Robichaux, Ashley H. Woodson, Dan S. Gombos, Steven G. Waguespack, Kamran Ahrar, Eric Jonasch, Justin A. Weldon, Nancy D. Perrier, Gregory N. Fuller, Diane Liu, Patrick G. Pilie, Ian E. McCutcheon
Publikováno v:
The Lancet Oncology. 19:1351-1359
Summary Background No approved systemic therapy exists for von Hippel-Lindau disease, an autosomal dominant disorder with pleiotropic organ manifestations that include clear cell renal cell carcinomas; retinal, cerebellar, and spinal haemangioblastom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::487b43f5a13e91585c8cd6b01400fb43
https://doi.org/10.1016/s1470-2045(18)30487-x
https://doi.org/10.1016/s1470-2045(18)30487-x
Autor:
Jennifer Wang, Nizar M. Tannir, Nicholas Spetsieris, Sijin Wen, Alexandros Tsikkinis, Ana Aparicio, Jeri Kim, Christopher J. Logothetis, Lance C. Pagliaro, Myrto Boukovala, Amado J. Zurita, Patricia Troncoso, Shi Ming Tu, Xuemei Wang, Paul G. Corn, Justin A. Weldon, Eleni Efstathiou, John C. Araujo, Anh Hoang, Sumit K. Subudhi
Publikováno v:
Clinical Genitourinary Cancer. 19:22-31.e5
Background Resistance to novel androgen signaling inhibition and metastatic castration-resistant prostate cancer (mCRPC) progression is likely dependent on tumor microenvironment interactions. The Src pathway and neoangiogenesis have been implicated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::236cf46ebf8c9c04ad830c25c68b2311
https://doi.org/10.1016/j.clgc.2020.05.013
https://doi.org/10.1016/j.clgc.2020.05.013
Autor:
Ana Aparicio, Justin A. Weldon, Ioannis Alafis, K. Karalis, Myrto Boukovala, Paul G. Corn, Nicholas Spetsieris, Eleni Efstathiou, S. M. Tu, Sumit K. Subudhi, John C. Araujo, Christopher J. Logothetis, Amado Zurita-Saavedra, M. Karlou
Publikováno v:
Annals of Oncology. 31:S524
Background: Advanced androgen signaling inhibition, a prevailing therapy approach in advanced prostate cancer, incurs variable response Therapy selection guided by predictors is an unmet need Methods: We reviewed MDACC GU department and Hellenic Sist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48df9dc5f61862a2861b82e7fd1c5d7a
https://doi.org/10.1016/j.annonc.2020.08.895
https://doi.org/10.1016/j.annonc.2020.08.895
Autor:
Curtis A. Pettaway, Sijin Wen, Paul G. Corn, Brian F. Chapin, John W. Davis, Louis L. Pisters, Eleni Efstathiou, Justin A. Weldon, Amado J. Zurita, Jennifer Wang, Sumit K. Subudhi, Christopher J. Logothetis, Patricia Troncoso, Myrto Boukovala, Anh Hoang, Ana Aparicio, Mehrad Adibi, Nicholas Spetsieris, Rebecca S. S. Tidwell, John Papadopoulos
Publikováno v:
Journal of Clinical Oncology. 38:5504-5504
5504 Background: Novel androgen signaling inhibitors (ASI) with medical castration may improve outcomes in LHRPC. We previously reported relapse free survival association with pathologic measures of tumor regression. However a wide range of persisten
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c302885c5f75ecc7fe1847cbb9652ac
https://doi.org/10.1200/jco.2020.38.15_suppl.5504
https://doi.org/10.1200/jco.2020.38.15_suppl.5504
Autor:
Valerie D. Marcott, Justin A. Weldon, Christine C Robichaux, Eric Jonasch, Ashley H. Woodson, Steven G. Waguespack, Nizar M. Tannir, Diane D. Liu, Surena F. Matin, Ian E. McCutcheon, Dan S. Gombos, Greg Fuller, Shelly Bird
Publikováno v:
Journal of Clinical Oncology. 35:4516-4516
4516 Background: Von Hippel-Lindau disease (VHL) is an autosomal dominant inherited disorder. Affected individuals develop vascular neoplastic lesions in multiple sites including eye, brain, pancreas, adrenal and kidney. Standards of care include sur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f7586f63b516952c52582534c9dade7
https://doi.org/10.1200/jco.2017.35.15_suppl.4516
https://doi.org/10.1200/jco.2017.35.15_suppl.4516